Genoskin Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 39


  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $61.6K

  • Investors
  • 4

Genoskin General Information


Developer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmaceutical, cosmetical and chemical products. The company's technology permits stable and long-term ex vivo cultivation of fresh human skin biopsies without loss of tissue integrity, morphology, physiology, and cutaneous barrier function, enabling pharmaceutical and cosmetic product companies to test on real human tissue collected after surgery which is kept alive through an ex vivo culture system to avoid animal experiments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 1, Place Pierre Potier
  • 31100 Toulouse
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genoskin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 23-Mar-2018 $61.6K Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
2. Grant 28-Jun-2011 Completed Startup
1. Accelerator/Incubator 01-Sep-2009 Completed Startup
To view Genoskin’s complete valuation and funding history, request access »

Genoskin Comparisons

HQ Location
Total Raised
Post Valuation
Developer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmaceutical, cosme
Toulouse, France
39 As of 2023


do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
Carlsbad, CA
00 As of 0000
000000000 -


fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
00000 00000000000000
Alameda, CA
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genoskin Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ScienCell Research Laboratories Corporation Carlsbad, CA 00 000000000 -
AllCells Private Equity-Backed Alameda, CA 00 000000000000
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 000 000.00 0000000000 0 000.00
MatTek Corporate Backed or Acquired Ashland, MA 000 000000&0
FUJIFILM Cellular Dynamics Formerly VC-backed Madison, WI 000 00000 000000&0 00000
You’re viewing 5 of 22 competitors. Get the full list »

Genoskin Patents

Genoskin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3132146-A1 Ex vivo human model intended for the evaluation of the vaccine potential of a composition Pending 27-Jan-2022 00000000000 00
FR-3123125-A1 Ex vivo human model intended for the evaluation of the inflammatory potential of the allergic or pseudo-allergic type Pending 20-May-2021 00000000000 0
EP-4341690-A1 Ex vivo human model intended for evaluating allergic or pseudo-allergic inflammatory potential Pending 20-May-2021 00000000000
EP-4182440-A1 Microfluidic system to control perfusion, diffusion and collection of molecules over long periods in an ex-vivo skin model Pending 16-Jul-2020 0000000000
EP-3940058-A1 Microfluidic system to control perfusion, diffusion and collection of molecules over long periods in an ex-vivo skin model Inactive 16-Jul-2020 C12N5/0698 0
To view Genoskin’s complete patent history, request access »

Genoskin Executive Team (5)

Name Title Board Seat Contact Info
Pascal Descargues Ph.D Founder, Chief Executive Officer & Président
Frederick Roques Chief Financial Officer
Claire Jardet Ph.D Chief Operations Officer
Nicolas Gaudenzio Ph.D Chief Scientific Officer
Eric Merle Chief Business Innovation Officer
To view Genoskin’s complete executive team members history, request access »

Genoskin Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genoskin Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
InnoVentures Lab Accelerator/Incubator Minority 000 0000 000000 0
OSEO Innovation Venture Capital Minority 000 0000 000000 0
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Genoskin’s complete investors history, request access »

Genoskin FAQs

  • When was Genoskin founded?

    Genoskin was founded in 2009.

  • Who is the founder of Genoskin?

    Pascal Descargues Ph.D is the founder of Genoskin.

  • Who is the CEO of Genoskin?

    Pascal Descargues Ph.D is the CEO of Genoskin.

  • Where is Genoskin headquartered?

    Genoskin is headquartered in Toulouse, France.

  • What is the size of Genoskin?

    Genoskin has 39 total employees.

  • What industry is Genoskin in?

    Genoskin’s primary industry is Biotechnology.

  • Is Genoskin a private or public company?

    Genoskin is a Private company.

  • What is Genoskin’s current revenue?

    The current revenue for Genoskin is 00000.

  • Who are Genoskin’s investors?

    Horizon 2020 SME Instrument, InnoVentures Lab, OSEO Innovation, and Nubbo have invested in Genoskin.

  • Who are Genoskin’s competitors?

    ScienCell Research Laboratories, AllCells, Aspect Biosystems, MatTek, and FUJIFILM Cellular Dynamics are some of the 22 competitors of Genoskin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »